Platelet-activating factor

被引:6
|
作者
Owen, John S. [1 ]
Thomas, Michael J. [1 ]
Wykle, Robert L. [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27109 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0076-6879(07)34006-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Platelet-activating factor (PAF) is a potent mediator that occurs at very low concentrations in cells and tissues. Accurate quantitation of PAF has always been difficult because of the physicochemical properties of PAF and its structural similarity to several much more abundant phospholipids. Numerous assays for PAF have been developed, all of which have their strengths and limitations. Herein, this chapter describes a high-pressure liquid chromatography (HPLC)tandem mass spectrometry assay for PAF. Major strengths of the method are its sensitivity (detection limit = 1 pg) and selectivity. Another advantage is that, by using liquid instead of gas chromatography, sample derivatization is avoided. The limitations of the method are its use of expensive instrumentation and the requirement of performing two HPLC runs per sample. Detailed technical advice on application of the method to various types of samples is given.
引用
收藏
页码:105 / 116
页数:12
相关论文
共 50 条
  • [31] MODULATION OF THE BIOSYNTHESIS OF PLATELET-ACTIVATING FACTOR
    SUGIURA, T
    UCHIYAMA, A
    MASUZAWA, Y
    FUJITA, M
    NAKAGAWA, Y
    WAKU, K
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 31 - 31
  • [32] CORONARY EFFECTS OF PLATELET-ACTIVATING FACTOR
    BOYD, LM
    EZRA, D
    SNYDER, F
    FEUERSTEIN, G
    GOLDSTEIN, RE
    CIRCULATION, 1983, 68 (04) : 34 - 34
  • [33] Role of platelet-activating factor in parturition
    Narahara, H
    Toyoshima, K
    Johnston, JM
    PLATELET-ACTIVATING FACTOR AND RELATED LIPID MEDIATORS 2: ROLES IN HEALTH AND DISEASE, 1996, 416 : 269 - 275
  • [34] MACROPHAGE ORIGIN OF PLATELET-ACTIVATING FACTOR
    MENCIAHUERTA, JM
    DUVAL, D
    BENVENISTE, J
    COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D, 1978, 286 (02): : 241 - 244
  • [35] A SUPERFUSION BIOASSAY FOR PLATELET-ACTIVATING FACTOR
    CIRINO, G
    WALLACE, JL
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1989, 67 (01) : 72 - 74
  • [36] PLATELET-ACTIVATING FACTOR IN RENAL DISEASES
    CAMUSSI, G
    SALVIDIO, G
    TETTA, C
    AMERICAN JOURNAL OF NEPHROLOGY, 1989, 9 : 23 - 26
  • [37] Platelet-activating factor and oxidized LDL
    Androulakis, N
    Aronis, P
    Tsoukatos, DC
    FREE RADICAL RESEARCH, 2003, 37 : 77 - 77
  • [38] Platelet-activating factor and human meningiomas
    Denizot, Y.
    De Armas, R.
    Caire, F.
    Pommepuy, I.
    Truffinet, V.
    Labrousse, F.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2006, 32 (06) : 674 - 678
  • [39] Platelet-activating factor in human meningiomas
    Labrousse, Francois
    De Armas, Rafael
    Caire, Francois
    Pommepuy, Isabelle
    Truffinet, Veronique
    Denizot, Yves
    BRAIN PATHOLOGY, 2006, 16 : S99 - S99
  • [40] THE FUNCTION OF PLATELET-ACTIVATING FACTOR IN ASTHMA
    UKENA, D
    SYBRECHT, GW
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (42) : 1651 - 1656